Pathlab update: FIB-4 Index (Liver fibrosis score)

Pathlab is now able to offer FIB-4 Index as a requestable test.

The FIB-4 Index is used to assess the risk of liver fibrosis in patients with Metabolic Associated Fatty Liver Disease (but is not appropriate for other causes of liver disease).

FIB-4 Index is a calculation which uses the patient’s age, and AST, ALT, and platelet results. Please see the Pathlab test website for FIB-4 limits and comments, which have been adopted from the Auckland Region Gastroenterology group. 

If using Pathlab Éclair orders, please go to the additional tab and search “FIB-4.”